An Integrated Epigenome and Transcriptome Analysis Identifies PAX2 as a Master Regulator of Drug Resistance in High Grade Pancreatic Ductal Adenocarcinoma

PLoS ONE - United States
doi 10.1371/journal.pone.0223554
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

A Feature-Based Analysis Identifies COL1A2 as a Regulator in Pancreatic Cancer

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2019English

Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review

PLoS ONE
Multidisciplinary
2016English

GATA3 as a Master Regulator and Therapeutic Target in Ovarian High-Grade Serous Carcinoma Stem Cells

International Journal of Cancer
Cancer ResearchOncology
2018English

Desmogleins as Prognostic Biomarkers in Resected Pancreatic Ductal Adenocarcinoma

British Journal of Cancer
Cancer ResearchOncology
2015English

Resection of Oligometastatic Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis

HPB
HepatologyGastroenterology
2019English

Transcriptome Analysis of the Rhodobacter Sphaeroides PpsR Regulon: PpsR as a Master Regulator of Photosystem Development

Journal of Bacteriology
MicrobiologyMolecular Biology
2005English

Open Chromatin Profiling Identifies AP1 as a Transcriptional Regulator in Oesophageal Adenocarcinoma

PLoS Genetics
EvolutionEcologyGeneticsMolecular BiologyCancer ResearchSystematicsBehavior
2017English

Reply To: Relationship Between LAT1 Expression and Resistance to Chemotherapy in Pancreatic Ductal Adenocarcinoma

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy